Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Max Lafontan

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Lipolysis

Anatomy

Chemicals & Drugs

Disorders

Obesity

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
88
Berlan, Michel
73
Galitzky, Jean
28
Valet, Philippe
25
Saulnier-Blache, Jean Sébastien
24
Crampes, François
22
Carpéné, Christian
21
Stich, Vladimir
21
Sengenes, Coralie
18
Moro, Cédric
17
De Glisezinski, Isabelle
15
Barbe, Pierre
15
Langin, Dominique
13
Bouloumié, Anne
11
Daviaud, Danièle
11
Thalamas, Claire

Sign-in to see all Coauthors

Publications

TOP 3
Duffaut Carine; Zakaroff-Girard Alexia; Bourlier Virginie; Decaunes Pauline; Maumus Marie; Chiotasso Patrick; Sengenès Coralie; Lafontan Max; Galitzky Jean; Bouloumié Anne
Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators.
Lafontan Max; Langin Dominique
Lipolysis and lipid mobilization in human adipose tissue.
Duffaut Carine; Galitzky Jean; Lafontan Max; Bouloumié Anne
Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Max Lafontan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Duffaut Carine; Zakaroff-Girard Alexia; Bourlier Virginie; Decaunes Pauline; Maumus Marie; Chiotasso Patrick; Sengenès Coralie; Lafontan Max; Galitzky Jean; Bouloumié Anne
Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(10):1608-14.
2009: Lafontan Max; Langin Dominique
Lipolysis and lipid mobilization in human adipose tissue.
Progress in lipid research 2009;48(5):275-97.
2009: Duffaut Carine; Galitzky Jean; Lafontan Max; Bouloumié Anne
Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity.
Biochemical and biophysical research communications 2009;384(4):482-5.
2009: de Glisezinski I; Larrouy D; Bajzova M; Koppo K; Polak J; Berlan M; Bulow J; Langin D; Marques M A; Crampes F; Lafontan M; Stich V
Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.
The Journal of physiology 2009;587(Pt 13):3393-404.
2008: Birkenfeld Andreas L; Budziarek Petra; Boschmann Michael; Moro Cedric; Adams Frauke; Franke Gabriele; Berlan Michel; Marques Marie A; Sweep Fred C G J; Luft Friedrich C; Lafontan Max; Jordan Jens
Atrial natriuretic peptide induces postprandial lipid oxidation in humans.
Diabetes 2008;57(12):3199-204.
2008: Maumus Marie; Sengenès Coralie; Decaunes Pauline; Zakaroff-Girard Alexia; Bourlier Virginie; Lafontan Max; Galitzky Jean; Bouloumié Anne
Evidence of in situ proliferation of adult adipose tissue-derived progenitor cells: influence of fat mass microenvironment and growth.
The Journal of clinical endocrinology and metabolism 2008;93(10):4098-106.
2008: Lafontan M; Girard J
Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.
Diabetes & metabolism 2008;34(4 Pt 1):317-27.
2008: Moro Cedric; Pillard Fabien; de Glisezinski Isabelle; Klimcakova Eva; Crampes Francois; Thalamas Claire; Harant Isabelle; Marques Marie-Adeline; Lafontan Max; Berlan Michel
Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men.
American journal of physiology. Endocrinology and metabolism 2008;295(2):E505-13.
2008: Lafontan Max; Moro Cédric; Berlan Michel; Crampes François; Sengenes Coralie; Galitzky Jean
Control of lipolysis by natriuretic peptides and cyclic GMP.
Trends in endocrinology and metabolism: TEM 2008;19(4):130-7.
2008: Bourlier V; Zakaroff-Girard A; Miranville A; De Barros S; Maumus M; Sengenes C; Galitzky J; Lafontan M; Karpe F; Frayn K N; Bouloumié A
Remodeling phenotype of human subcutaneous adipose tissue macrophages.
Circulation 2008;117(6):806-15.
2007: Moro C; Klimcakova E; Lafontan M; Berlan M; Galitzky J
Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.
British journal of pharmacology 2007;152(7):1102-10.
2007: Polak Jan; Moro Cédric; Bessière David; Hejnova Jindra; Marquès Marie A; Bajzova Magda; Lafontan Max; Crampes Francois; Berlan Michel; Stich Vladimir
Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue.
Journal of lipid research 2007;48(10):2236-46.
2007: Pillard Fabien; Moro Cédric; Harant Isabelle; Garrigue Eric; Lafontan Max; Berlan Michel; Crampes François; de Glisezinski Isabelle; Rivière Daniel
Lipid oxidation according to intensity and exercise duration in overweight men and women.
Obesity (Silver Spring, Md.) 2007;15(9):2256-62.
2007: Moro Cédric; Pillard Fabien; de Glisezinski Isabelle; Crampes François; Thalamas Claire; Harant Isabelle; Marques Marie-Adeline; Lafontan Max; Berlan Michel
Sex differences in lipolysis-regulating mechanisms in overweight subjects: effect of exercise intensity.
Obesity (Silver Spring, Md.) 2007;15(9):2245-55.
2007: Moro Cédric; Pillard Fabien; de Glisezinski Isabelle; Crampes Francois; Thalamas Claire; Harant Isabelle; Marques Marie-Adeline; Lafontan Max; Berlan Michel
Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;293(2):R612-7.
2007: Moro C; Klimcakova E; Lolmède K; Berlan M; Lafontan M; Stich V; Bouloumié A; Galitzky J; Arner P; Langin D
Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.
Diabetologia 2007;50(5):1038-47.
2007: De Barros Sandra; Zakaroff-Girard Alexia; Lafontan Max; Galitzky Jean; Bourlier Virginie
Inhibition of human preadipocyte proteasomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix metalloproteinase-9.
The Journal of pharmacology and experimental therapeutics 2007;320(1):291-9.
2006: Birkenfeld Andreas L; Boschmann Michael; Moro Cedric; Adams Frauke; Heusser Karsten; Tank Jens; Diedrich André; Schroeder Christoph; Franke Gabi; Berlan Michel; Luft Friedrich C; Lafontan Max; Jordan Jens
Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.
The Journal of clinical endocrinology and metabolism 2006;91(12):5069-75.
2006: Lafontan Max; Viguerie Nathalie
Role of adipokines in the control of energy metabolism: focus on adiponectin.
Current opinion in pharmacology 2006;6(6):580-5.
2006: Moro Cédric; Polak Jan; Hejnova Jindra; Klimcakova Eva; Crampes François; Stich Vladimir; Lafontan Max; Berlan Michel
Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise.
American journal of physiology. Endocrinology and metabolism 2006;290(5):E864-9.
2006: Moro Cédric; Berlan Michel; Lafontan Max
[Physiological and pathophysiological features of the control of lipolysis and lipid mobilization by natriuretic peptides]
Journal de la Société de biologie 2006;200(1):67-76.
2005: Sengenes Coralie; Moro Cédric; Galitzky Jean; Berlan Michel; Lafontan Max
[Natriuretic peptides: a new lipolytic pathway in human fat cells]
Médecine sciences : M/S 2005;21 Spec No():29-33.
2005: Polak J; Moro C; Klimcakova E; Hejnova J; Majercik M; Viguerie N; Langin D; Lafontan M; Stich V; Berlan M
Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects.
Diabetologia 2005;48(12):2631-40.
2005: Lafontan Max; Moro Cédric; Sengenes Coralie; Galitzky Jean; Crampes François; Berlan Michel
An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2032-42.
2005: Tavernier Geneviève; Jimenez Maria; Giacobino Jean-Paul; Hulo Nicolas; Lafontan Max; Muzzin Patrick; Langin Dominique
Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice.
Molecular pharmacology 2005;68(3):793-9.
2005: Moro Cedric; Pillard Fabien; De Glisezinski Isabelle; Harant Isabelle; Rivière Daniel; Stich Vladimir; Lafontan Max; Crampes François; Berlan Michel
Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men.
Medicine and science in sports and exercise 2005;37(7):1126-32.
2005: Birkenfeld Andreas L; Boschmann Michael; Moro Cedric; Adams Frauke; Heusser Karsten; Franke Gabriele; Berlan Michel; Luft Friedrich C; Lafontan Max; Jordan Jens
Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans.
The Journal of clinical endocrinology and metabolism 2005;90(6):3622-8.
2005: Bourlier Virginie; Zakaroff-Girard Alexia; De Barros Sandra; Pizzacalla Christophe; de Saint Front Véronique Durand; Lafontan Max; Bouloumié Anne; Galitzky Jean
Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation.
The Journal of pharmacology and experimental therapeutics 2005;312(3):1272-9.
2005: Sengenes Coralie; Moro Cédric; Galitzky Jean; Berlan Michel; Lafontan Max
[Natriuretic peptides: a new lipolytic pathway in human fat cells]
Médecine sciences : M/S 2005;21(1):61-5.
2005: Moro Cédric; Polak Jan; Richterova Blanka; Sengenès Coralie; Pelikanova Terezie; Galitzky Jean; Stich Vladimir; Lafontan Max; Berlan Michel
Differential regulation of atrial natriuretic peptide- and adrenergic receptor-dependent lipolytic pathways in human adipose tissue.
Metabolism: clinical and experimental 2005;54(1):122-31.
2005: Lafontan Max
Fat cells: afferent and efferent messages define new approaches to treat obesity.
Annual review of pharmacology and toxicology 2005;45():119-46.
2004: Moro Cedric; Crampes Francois; Sengenes Coralie; De Glisezinski Isabelle; Galitzky Jean; Thalamas Claire; Lafontan Max; Berlan Michel
Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(7):908-10.
2004: Richterova B; Stich V; Moro C; Polak J; Klimcakova E; Majercik M; Harant I; Viguerie N; Crampes F; Langin D; Lafontan M; Berlan M
Effect of endurance training on adrenergic control of lipolysis in adipose tissue of obese women.
The Journal of clinical endocrinology and metabolism 2004;89(3):1325-31.
2004: Moro Cedric; Galitzky Jean; Sengenes Coralie; Crampes François; Lafontan Max; Berlan Michel
Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
The Journal of pharmacology and experimental therapeutics 2004;308(3):984-92.
2003: Sengenes Coralie; Bouloumie Anne; Hauner Hans; Berlan Michel; Busse Rudi; Lafontan Max; Galitzky Jean
Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.
The Journal of biological chemistry 2003;278(49):48617-26.
2003: Lolmède K; Durand de Saint Front V; Galitzky J; Lafontan M; Bouloumié A
Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(10):1187-95.
2003: Stich Vladimir; Pelikanova Tereza; Wohl Petr; Sengenès Coralie; Zakaroff-Girard Alexia; Lafontan Max; Berlan Michel
Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men.
American journal of physiology. Endocrinology and metabolism 2003;285(3):E599-607.
2003: Mérial-Kieny Christelle; Lonchampt Michel; Cogé Francis; Verwaerde Patrick; Galizzi Jean-Pierre; Boutin Jean A; Lafontan Max; Levens Nigel; Galitzky Jean; Félétou Michel
Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes.
British journal of pharmacology 2003;139(5):935-44.
2003: Lafontan Max; Berlan Michel
Do regional differences in adipocyte biology provide new pathophysiological insights?
Trends in pharmacological sciences 2003;24(6):276-83.
2003: Gesta S; Lolmède K; Daviaud D; Berlan M; Bouloumié A; Lafontan M; Valet P; Saulnier-Blache J S
Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(3):158-63.
2003: Marion-Latard F; Crampes F; Zakaroff-Girard A; De Glisezinski I; Harant I; Stich V; Thalamas C; Rivière D; Lafontan M; Berlan M
Post-exercise increase of lipid oxidation after a moderate exercise bout in untrained healthy obese men.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(2):97-103.
2003: Crampes Francois; Marion-Latard Fabrice; Zakaroff-Girard Alexia; De Glisezinski Isabelle; Harant Isabelle; Thalamas Claire; Stich Vladimir; Rivière Daniel; Lafontan Max; Berlan Michel
Effects of a longitudinal training program on responses to exercise in overweight men.
Obesity research 2003;11(2):247-56.
2003: Pelat Michel; Verwaerde Patrick; Galitzky Jean; Lafontan Max; Berlan Michel; Senard Jean-Michel; Montastruc Jean-Louis
High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
The Journal of pharmacology and experimental therapeutics 2003;304(1):246-53.
2002: Boucher J; Castan-Laurell I; Le Lay S; Grujic D; Sibrac D; Krief S; Lafontan M; Lowell B B; Dugail I; Saulnier-Blache J-S; Valet P
Human alpha 2A-adrenergic receptor gene expressed in transgenic mouse adipose tissue under the control of its regulatory elements.
Journal of molecular endocrinology 2002;29(2):251-64.
2002: Berlan Michel; Verhaeghe Stephan; Pavy-Le Traon Anne; Thalamas Claire; Lafontan Max; Marques Marie Adeline; Senard Jean Michel; Parent Marc; Galitzky Jean
Yohimbine administration prevents over-responsiveness to epinephrine induced by simulated microgravity.
Aviation, space, and environmental medicine 2002;73(8):735-42.
2002: Sengenès Coralie; Zakaroff-Girard Alexia; Moulin Agnès; Berlan Michel; Bouloumié Anne; Lafontan Max; Galitzky Jean
Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity.
American journal of physiology. Regulatory, integrative and comparative physiology 2002;283(1):R257-65.
2002: Gesta Stéphane; Simon Marie-Françoise; Rey Astrid; Sibrac David; Girard Alexia; Lafontan Max; Valet Philippe; Saulnier-Blache Jean Sébastien
Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis.
Journal of lipid research 2002;43(6):904-10.
2002: Bouloumié A; Lolmède K; Sengenès C; Galitzky J; Lafontan M
Angiogenesis in adipose tissue.
Annales d'endocrinologie 2002;63(2 Pt 1):91-5.
2002: Lafontan M; Berlan M; Stich V; Crampes F; Rivière D; De Glisezinski I; Sengenes C; Galitzky J
Recent data on the regulation of lipolysis by catecholamines and natriuretic peptides.
Annales d'endocrinologie 2002;63(2 Pt 1):86-90.
2002: Stich V; Marion-Latard F; Hejnova J; Viguerie N; Lefort C; Suljkovicova H; Langin D; Lafontan M; Berlan M
Hypocaloric diet reduces exercise-induced alpha 2-adrenergic antilipolytic effect and alpha 2-adrenergic receptor mRNA levels in adipose tissue of obese women.
The Journal of clinical endocrinology and metabolism 2002;87(3):1274-81.
2002: Castan-Laurell I; Boucher J; Rey A; Sibrac D; Gesta S; Pagès C; Daviaud D; Simon M F; Lafontan M; Saulnier-Blachet J S; Valet P
[Development of nutritional obesity in transgenic mice with an adrenergic receptivity in adipose tissue comparable with that of humans]
Pathologie-biologie 2002;50(1):52-7.
2002: Smih Fatima; Rouet Philippe; Lucas Stéphanie; Mairal Aline; Sengenes Coralie; Lafontan Max; Vaulont Sophie; Casado Marta; Langin Dominique
Transcriptional regulation of adipocyte hormone-sensitive lipase by glucose.
Diabetes 2002;51(2):293-300.
2002: Sengenes C; Stich V; Berlan M; Hejnova J; Lafontan M; Pariskova Z; Galitzky J
Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(1):24-32.
2001: Lafontan M
[Lipid metabolism in adipose tissue: adrenergic control of the adipocyte and mobilization if the lipids]
Annales d'endocrinologie 2001;62(4 Pt 2):S7-17.
2001: Bouloumié A; Sengenès C; Portolan G; Galitzky J; Lafontan M
Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation.
Diabetes 2001;50(9):2080-6.
2001: Carpéné C; Morin N; Fontana E; Visentin V; Prévot D; Marti L; Lafontan M
Histamine weakly stimulates lipolysis and is poorly oxidized by amine oxidases in human subcutaneous fat cells.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2001;50 Suppl 2():S140-1.
2001: Galitzky J; Sengenès C; Thalamas C; Marques M A; Senard J M; Lafontan M; Berlan M
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men.
Journal of lipid research 2001;42(4):536-44.
2001: Pages C; Daviaud D; An S; Krief S; Lafontan M; Valet P; Saulnier-Blache J S
Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading.
The Journal of biological chemistry 2001;276(15):11599-605.
2000: Lafontan M; Berlan M; Galitzky J
[Lipid mobilization and energy metabolism: impact of molecular and cellular approaches on the treatment of obesity]
Annales d'endocrinologie 2000;61 Suppl 6():56-69.
2000: Saulnier-Blache J S; Girard A; Simon M F; Lafontan M; Valet P
A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification.
Journal of lipid research 2000;41(12):1947-51.
2000: Langin D; Lucas S; Lafontan M
Millennium fat-cell lipolysis reveals unsuspected novel tracks.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2000;32(11-12):443-52.
2000: Lafontan M; Sengenes C; Galitzky J; Berlan M; De Glisezinski I; Crampes F; Stich V; Langin D; Barbe P; Rivière D
Recent developments on lipolysis regulation in humans and discovery of a new lipolytic pathway.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24 Suppl 4():S47-52.
2000: Valet P; Grujic D; Wade J; Ito M; Zingaretti M C; Soloveva V; Ross S R; Graves R A; Cinti S; Lafontan M; Lowell B B
Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity.
The Journal of biological chemistry 2000;275(44):34797-802.
2000: Merial C; Bouloumie A; Trocheris V; Lafontan M; Galitzky J
Nitric oxide-dependent downregulation of adipocyte UCP-2 expression by tumor necrosis factor-alpha.
American journal of physiology. Cell physiology 2000;279(4):C1100-6.
2000: Stich V; De Glisezinski I; Crampes F; Hejnova J; Cottet-Emard J M; Galitzky J; Lafontan M; Rivière D; Berlan M
Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects.
American journal of physiology. Regulatory, integrative and comparative physiology 2000;279(2):R499-504.
2000: Sengenès C; Berlan M; De Glisezinski I; Lafontan M; Galitzky J
Natriuretic peptides: a new lipolytic pathway in human adipocytes.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(10):1345-51.
2000: Thalamas C; Galitzky J; Sénard J M; Lafontan M; Montastruc J L; Berlan M; Barbe P
Glucose-induced sympathetic activity and energy expenditure during acute alpha2-adrenergic antagonism in obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(6):695-700.
2000: Pagès G; Girard A; Jeanneton O; Barbe P; Wolf C; Lafontan M; Valet P; Saulnier-Blache J S
LPA as a paracrine mediator of adipocyte growth and function.
Annals of the New York Academy of Sciences 2000;905():159-64.
2000: Stich V; de Glisezinski I; Berlan M; Bulow J; Galitzky J; Harant I; Suljkovicova H; Lafontan M; Rivière D; Crampes F
Adipose tissue lipolysis is increased during a repeated bout of aerobic exercise.
Journal of applied physiology (Bethesda, Md. : 1985) 2000;88(4):1277-83.
1999: Pizzinat N; Marti L; Remaury A; Leger F; Langin D; Lafontan M; Carpéné C; Parini A
High expression of monoamine oxidases in human white adipose tissue: evidence for their involvement in noradrenaline clearance.
Biochemical pharmacology 1999;58(11):1735-42.
1999: Barbe P; Galitzky J; Thalamas C; Langin D; Lafontan M; Senard J M; Berlan M
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humans.
Journal of applied physiology (Bethesda, Md. : 1985) 1999;87(5):1614-20.
1999: Pagès C; Rey A; Lafontan M; Valet P; Saulnier-Blache J S
Ca(2+)-independent phospholipase A2 is required for alpha2-adrenergic-induced preadipocyte spreading.
Biochemical and biophysical research communications 1999;265(2):572-6.
1999: Stich V; de Glisezinski I; Crampes F; Suljkovicova H; Galitzky J; Riviere D; Hejnova J; Lafontan M; Berlan M
Activation of antilipolytic alpha(2)-adrenergic receptors by epinephrine during exercise in human adipose tissue.
The American journal of physiology 1999;277(4 Pt 2):R1076-83.
1999: Verwaerde P; Sénard J M; Galinier M; Rougé P; Massabuau P; Galitzky J; Berlan M; Lafontan M; Montastruc J L
Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs.
Journal of hypertension 1999;17(8):1135-43.
1999: Bouloumie A; Marumo T; Lafontan M; Busse R
Leptin induces oxidative stress in human endothelial cells.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(10):1231-8.
1999: Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(4):310-21.
1999: Bousquet-Mélou A; Muñoz C; Galitzky J; Berlan M; Lafontan M
Pregnancy modifies the alpha2-beta-adrenergic receptor functional balance in rabbit fat cells.
Journal of lipid research 1999;40(2):267-74.
1999: Pagès C; Valet P; Jeanneton O; Zakaroff-Girard A; Barbe P; Record M; Wolf C; Chevy F; Lafontan M; Saulnier-Blache J S
Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes: a paracrine signal for preadipocyte growth.
Lipids 1999;34 Suppl():S79.
1999: Montastruc J L; Verwaerde P; Pelat M; Galitzky J; Langin D; Lafontan M; Berlan M
Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
Fundamental & clinical pharmacology 1999;13(2):180-6.
1998: Bouloumié A; Drexler H C; Lafontan M; Busse R
Leptin, the product of Ob gene, promotes angiogenesis.
Circulation research 1998;83(10):1059-66.
1998: Millet L; Barbe P; Lafontan M; Berlan M; Galitzky J
Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue.
Journal of applied physiology (Bethesda, Md. : 1985) 1998;85(1):181-8.
1998: Bétuing S; Daviaud D; Pagès C; Bonnard E; Valet P; Lafontan M; Saulnier-Blache J S
Gbeta gamma-independent coupling of alpha2-adrenergic receptor to p21(rhoA) in preadipocytes.
The Journal of biological chemistry 1998;273(25):15804-10.
1998: Marti L; Morin N; Enrique-Tarancon G; Prevot D; Lafontan M; Testar X; Zorzano A; Carpéné C
Tyramine and vanadate synergistically stimulate glucose transport in rat adipocytes by amine oxidase-dependent generation of hydrogen peroxide.
The Journal of pharmacology and experimental therapeutics 1998;285(1):342-9.
1998: Valet P; Pagès C; Jeanneton O; Daviaud D; Barbe P; Record M; Saulnier-Blache J S; Lafontan M
Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.
The Journal of clinical investigation 1998;101(7):1431-8.
1998: Barbe P; Galitzky J; De Glisezinski I; Riviere D; Thalamas C; Senard J M; Crampes F; Lafontan M; Berlan M
Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue.
The Journal of clinical endocrinology and metabolism 1998;83(2):619-25.
1998: Lafontan M; Betuing S; Saulnier-Blache J S; Valet P; Bouloumié A; Carpéné C; Galitzky J; Berlan M
Regulation of fat-cell function by alpha 2-adrenergic receptors.
Advances in pharmacology (San Diego, Calif.) 1998;42():496-8.
1997: Galitzky J; Langin D; Verwaerde P; Montastruc J L; Lafontan M; Berlan M
Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
British journal of pharmacology 1997;122(6):1244-50.
1997: Lafontan M; Barbe P; Galitzky J; Tavernier G; Langin D; Carpéné C; Bousquet-Melou A; Berlan M
Adrenergic regulation of adipocyte metabolism.
Human reproduction (Oxford, England) 1997;12 Suppl 1():6-20.
1997: Raclot T; Langin D; Lafontan M; Groscolas R
Selective release of human adipocyte fatty acids according to molecular structure.
The Biochemical journal 1997;324 ( Pt 3)():911-5.
1997: Bétuing S; Valet P; Lapalu S; Peyroulan D; Hickson G; Daviaud D; Lafontan M; Saulnier-Blache J S
Functional consequences of constitutively active alpha2A-adrenergic receptor expression in 3T3F442A preadipocytes and adipocytes.
Biochemical and biophysical research communications 1997;235(3):765-73.
1997: Stich V; Harant I; De Glisezinski I; Crampes F; Berlan M; Kunesova M; Hainer V; Dauzats M; Rivière D; Garrigues M; Holm C; Lafontan M; Langin D
Adipose tissue lipolysis and hormone-sensitive lipase expression during very-low-calorie diet in obese female identical twins.
The Journal of clinical endocrinology and metabolism 1997;82(3):739-44.
1997: Barbe P; Stich V; Galitzky J; Kunesova M; Hainer V; Lafontan M; Berlan M
In vivo increase in beta-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet.
The Journal of clinical endocrinology and metabolism 1997;82(1):63-9.
1996: Atgié C; Tavernier G; D'Allaire F; Bengtsson T; Marti L; Carpéné C; Lafontan M; Bukowiecki L J; Langin D
Beta 3-adrenoceptor in guinea pig brown and white adipocytes: low expression and lack of function.
The American journal of physiology 1996;271(6 Pt 2):R1729-38.
1996: Bétuing S; Daviaud D; Valet P; Bouloumié A; Lafontan M; Saulnier-Blache J S
alpha2-Adrenoceptor stimulation promotes actin polymerization and focal adhesion in 3T3F442A and BFC-1beta preadipocytes.
Endocrinology 1996;137(12):5220-9.
1996: Barbe P; Millet L; Galitzky J; Lafontan M; Berlan M
In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
British journal of pharmacology 1996;117(5):907-13.
1996: Langin D; Holm C; Lafontan M
Adipocyte hormone-sensitive lipase: a major regulator of lipid metabolism.
The Proceedings of the Nutrition Society 1996;55(1B):93-109.
1996: Tavernier G; Barbe P; Galitzky J; Berlan M; Caput D; Lafontan M; Langin D
Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.
Journal of lipid research 1996;37(1):87-97.
1995: Lafontan M; Berlan M
Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis.
Endocrine reviews 1995;16(6):716-38.
1995: Lafontan M; Bousquet-Melou A; Galitzky J; Barbe P; Carpéné C; Langin D; Berlan M; Valet P; Castan I; Bouloumié A
Adrenergic receptors and fat cells: differential recruitment by physiological amines and homologous regulation.
Obesity research 1995;3 Suppl 4():507S-514S.
1995: Carpéné C; Marti L; Hudson A; Lafontan M
Nonadrenergic imidazoline binding sites and amine oxidase activities in fat cells.
Annals of the New York Academy of Sciences 1995;763():380-97.
1995: Tavernier G; Galitzky J; Valet P; Remaury A; Bouloumie A; Lafontan M; Langin D
Molecular mechanisms underlying regional variations of catecholamine-induced lipolysis in rat adipocytes.
The American journal of physiology 1995;268(6 Pt 1):E1135-42.
1995: Bousquet-Mélou A; Galitzky J; Moreno C M; Berlan M; Lafontan M
Desensitization of beta-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesterase.
European journal of pharmacology 1995;289(2):235-47.
1995: Bousquet-Mélou A; Galitzky J; Lafontan M; Berlan M
Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans.
Journal of lipid research 1995;36(3):451-61.
1995: Lafontan M; Langin D
Cellular aspects of fuel mobilization and selection in white adipocytes.
The Proceedings of the Nutrition Society 1995;54(1):49-63.
1995: Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
The Journal of pharmacology and experimental therapeutics 1995;272(2):681-8.
1995: Castan I; Devedjian J C; Valet P; Paris H; Lafontan M
Human adipocytes express alpha 2-adrenergic receptor of the alpha 2A-subtype only: pharmacological and genetic evidence.
Fundamental & clinical pharmacology 1995;9(6):569-75.
1995: Galitzky J; Carpéné C; Bousquet-Mélou A; Berlan M; Lafontan M
Differential activation of beta 1-, beta 2- and beta 3-adrenoceptors by catecholamines in white and brown adipocytes.
Fundamental & clinical pharmacology 1995;9(4):324-31.
1995: Berlan M; Barbe P; Stich V; Galitzky J; Bousquet-Mélou A; Lafontan M
[Lipid mobilization, physiopathological and pharmacological aspects]
Annales d'endocrinologie 1995;56(2):97-100.
1995: Langin D; Tavernier G; Lafontan M
Regulation of beta 3-adrenoceptor expression in white fat cells.
Fundamental & clinical pharmacology 1995;9(2):97-106.
1994: Bouloumié A; Planat V; Devedjian J C; Valet P; Saulnier-Blache J S; Record M; Lafontan M
Alpha 2-adrenergic stimulation promotes preadipocyte proliferation. Involvement of mitogen-activated protein kinases.
The Journal of biological chemistry 1994;269(48):30254-9.
1994: Bouloumie A; Valet P; Dauzats M; Lafontan M; Saulnier-Blache J S
In vivo upregulation of adipocyte alpha 2-adrenoceptors by androgens is consequence of direct action on fat cells.
The American journal of physiology 1994;267(4 Pt 1):C926-31.
1994: Bouloumié A; Valet P; Daviaud D; Prats H; Lafontan M; Saulnier-Blache J S
Adipocyte alpha 2A-adrenoceptor is the only alpha 2-adrenoceptor regulated by testosterone.
European journal of pharmacology 1994;269(1):95-103.
1994: Bousquet-Mélou A; Galitzky J; Carpéné C; Lafontan M; Berlan M
beta-Adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals.
The American journal of physiology 1994;267(1 Pt 2):R115-23.
1994: Lafontan M
Differential recruitment and differential regulation by physiological amines of fat cell beta-1, beta-2 and beta-3 adrenergic receptors expressed in native fat cells and in transfected cell lines.
Cellular signalling 1994;6(4):363-92.
1994: Larrouy D; Remaury A; Daviaud D; Lafontan M
Coupling of inhibitory receptors with Gi-proteins in hamster adipocytes: comparison between adenosine A1 receptor and alpha 2-adrenoceptor.
European journal of pharmacology 1994;267(2):225-32.
1994: Castan I; Valet P; Quideau N; Voisin T; Ambid L; Laburthe M; Lafontan M; Carpéné C
Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes.
The American journal of physiology 1994;266(4 Pt 2):R1141-7.
1994: Carpéné C; Castan I; Collon P; Galitzky J; Moratinos J; Lafontan M
Adrenergic lipolysis in guinea pig is not a beta 3-adrenergic response: comparison with human adipocytes.
The American journal of physiology 1994;266(3 Pt 2):R905-13.
1994: Carpéné C; Ambid L; Lafontan M
Predominance of beta 3-adrenergic component in catecholamine activation of lipolysis in garden dormouse adipocytes.
The American journal of physiology 1994;266(3 Pt 2):R896-904.
1994: Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc J L
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1444-51.
1993: Cousin B; Casteilla L; Lafontan M; Ambid L; Langin D; Berthault M F; Pénicaud L
Local sympathetic denervation of white adipose tissue in rats induces preadipocyte proliferation without noticeable changes in metabolism.
Endocrinology 1993;133(5):2255-62.
1993: Carpéné C; Chalaux E; Lizarbe M; Estrada A; Mora C; Palacin M; Zorzano A; Lafontan M; Testar X
Beta 3-adrenergic receptors are responsible for the adrenergic inhibition of insulin-stimulated glucose transport in rat adipocytes.
The Biochemical journal 1993;296 ( Pt 1)():99-105.
1993: Castan I; Valet P; Larrouy D; Voisin T; Remaury A; Daviaud D; Laburthe M; Lafontan M
Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the alpha 2-adrenergic system.
The American journal of physiology 1993;265(1 Pt 1):E74-80.
1993: Barbe P; Galitzky J; Riviere D; Senard J M; Lafontan M; Garrigues M; Berlan M
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man.
British journal of clinical pharmacology 1993;36(1):25-30.
1993: Lafontan M; Berlan M
Fat cell adrenergic receptors and the control of white and brown fat cell function.
Journal of lipid research 1993;34(7):1057-91.
1993: Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M
Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
The Journal of pharmacology and experimental therapeutics 1993;266(1):358-66.
1993: Galitzky J; Lafontan M; Nordenström J; Arner P
Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue.
The Journal of clinical investigation 1993;91(5):1997-2003.
1993: Carpéné C; Galitzky J; Collon P; Esclapez F; Dauzats M; Lafontan M
Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
The Journal of pharmacology and experimental therapeutics 1993;265(1):237-47.
1993: Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
The American journal of physiology 1993;264(3 Pt 1):E403-12.
1993: Galitzky J; Carpene C; Lafontan M; Berlan M
[Specific stimulation of adipose tissue adrenergic beta 3 receptors by octopamine]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(5):519-23.
1992: Castan I; Valet P; Voisin T; Quideau N; Laburthe M; Lafontan M
Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
Endocrinology 1992;131(4):1970-6.
1992: Lafontan M; Langin D; Portillo M; Paris H
Imidazoline binding sites in fat cells. Localization and pharmacologic differentiation from alpha 2-adrenergic receptors.
American journal of hypertension 1992;5(4 Pt 2):72S-79S.
1992: Lafontan M; Berlan M; Galitzky J; Montastruc J L
Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies.
The American journal of clinical nutrition 1992;55(1 Suppl):219S-227S.
1992: Saulnier-Blache J S; Bouloumie A; Valet P; Devedjian J C; Lafontan M
Androgenic regulation of adipocyte alpha 2-adrenoceptor expression in male and female Syrian hamsters: proposed transcriptional mechanism.
Endocrinology 1992;130(1):316-27.
1992: Langin D; Portillo M; Dauzats M; Lafontan M
Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits.
Endocrinology 1992;130(1):307-15.
1991: Galitzky J; Vermorel M; Lafontan M; Montastruc P; Berlan M
Thermogenic and lipolytic effect of yohimbine in the dog.
British journal of pharmacology 1991;104(2):514-8.
1991: Saulnier-Blache J S; Dauzats M; Daviaud D; Gaillard D; Ailhaud G; Négrel R; Lafontan M
Late expression of alpha 2-adrenergic-mediated antilipolysis during differentiation of hamster preadipocytes.
Journal of lipid research 1991;32(9):1489-99.
1991: Langin D; Portillo M P; Saulnier-Blache J S; Lafontan M
Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species.
European journal of pharmacology 1991;199(3):291-301.
1991: Berlan M; Galitzky J; Riviere D; Foureau M; Tran M A; Flores R; Louvet J P; Houin G; Lafontan M
Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.
International journal of obesity 1991;15(5):305-15.
1991: Larrouy D; Galitzky J; Lafontan M
A1 adenosine receptors in the human fat cell: tissue distribution and regulation of radioligand binding.
European journal of pharmacology 1991;206(2):139-47.
1990: Saulnier-Blache J S; Larrouy D; Carpéné C; Quideau N; Dauzats M; Lafontan M
Photoperiodic control of adipocyte alpha 2-adrenoceptors in Syrian hamsters: role of testosterone.
Endocrinology 1990;127(3):1245-53.
1990: Galitzky J; Senard J M; Lafontan M; Stillings M; Montastruc J L; Berlan M
Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
British journal of pharmacology 1990;100(4):862-6.
1990: Carpéné C; Galitzky J; Larrouy D; Langin D; Lafontan M
Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.
Biochemical pharmacology 1990;40(3):437-45.
1990: Carpéné C; Galitzky J; Saulnier-Blache J S; Lafontan M
Selective reduction of alpha 2-adrenergic responsiveness in hamster adipose tissue during prolonged starvation.
The American journal of physiology 1990;259(1 Pt 1):E80-8.
1990: Langin D; Paris H; Lafontan M
Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites.
Molecular pharmacology 1990;37(6):876-85.
1990: Saulnier-Blache J S; Atgie C; Carpene C; Quideau N; Lafontan M
Hamster adipocyte alpha 2-adrenoceptor changes during fat mass modifications are not directly dependent on adipose tissue norepinephrine content.
Endocrinology 1990;126(5):2425-34.
1990: Langin D; Paris H; Dauzats M; Lafontan M
Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells.
European journal of pharmacology 1990;188(4-5):261-72.
1990: Valet P; Berlan M; Beauville M; Crampes F; Montastruc J L; Lafontan M
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
The Journal of clinical investigation 1990;85(1):291-5.
1990: Galitzky J; Larrouy D; Berlan M; Lafontan M
New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
The Journal of pharmacology and experimental therapeutics 1990;252(1):312-9.
1989: Saulnier-Blache J S; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
The Journal of pharmacology and experimental therapeutics 1989;251(3):1187-92.
1989: Saulnier-Blache J S; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
The Journal of pharmacology and experimental therapeutics 1989;251(3):1193-8.
1989: Saulnier-Blache J S; Carpéné C; Langin D; Lafontan M
Imidazolinic radioligands for the identification of hamster adipocyte alpha 2-adrenoceptors.
European journal of pharmacology 1989;171(2-3):145-57.
1989: Langin D; Lafontan M; Stillings M R; Paris H
[3H]RX821002: a new tool for the identification of alpha 2A-adrenoceptors.
European journal of pharmacology 1989;167(1):95-104.
1989: Galitzky J; Lafontan M; Paris H; Berlan M
Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
The Journal of pharmacology and experimental therapeutics 1989;249(2):592-600.
1989: Galitzky J; Mauriege P; Berlan M; Lafontan M
Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
The Journal of pharmacology and experimental therapeutics 1989;249(2):583-91.
1989: Valet P; Taouis M; Tran M A; Montastruc P; Lafontan M; Berlan M
Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects.
British journal of pharmacology 1989;97(1):229-39.
1989: Valet P; Montastruc J L; Berlan M; Tran M A; Lafontan M; Montastruc P
Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog.
The Journal of pharmacology and experimental therapeutics 1989;249(1):271-7.
1989: Langin D; Lafontan M
[3H]idazoxan binding at non-alpha 2-adrenoceptors in rabbit adipocyte membranes.
European journal of pharmacology 1989;159(2):199-203.
1989: Crampes F; Marceron M; Beauville M; Riviere D; Garrigues M; Berlan M; Lafontan M
Platelet alpha 2-adrenoceptors and adrenergic adipose tissue responsiveness after moderate hypocaloric diet in obese subjects.
International journal of obesity 1989;13(1):99-110.
1988: Galitzky J; Taouis M; Berlan M; Rivière D; Garrigues M; Lafontan M
Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers.
European journal of clinical investigation 1988;18(6):587-94.
1988: Taouis M; Berlan M; Montastruc P; Lafontan M
Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog.
The Journal of pharmacology and experimental therapeutics 1988;247(3):1172-80.
1988: Crampes F; Beauville M; Riviere D; Garrigues M; Lafontan M
Lack of desensitization of catecholamine-induced lipolysis in fat cells from trained and sedentary women after physical exercise.
The Journal of clinical endocrinology and metabolism 1988;67(5):1011-7.
1988: Mauriège P; De Pergola G; Berlan M; Lafontan M
Human fat cell beta-adrenergic receptors: beta-agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta 1-antagonists.
Journal of lipid research 1988;29(5):587-601.
1988: Lafontan M; Berlan M; Prud'Hon M
[Beta adrenergic agonists. Mechanisms of action: lipid mobilization and anabolism]
Reproduction, nutrition, development 1988;28(1):61-84.
1987: Taouis M; Berlan M; Montastruc P; Lafontan M
Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.
The Journal of pharmacology and experimental therapeutics 1987;242(3):1041-9.

Sign-in to see more